首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1596897

藥物傳輸市場規模、佔有率、成長分析、按給藥途徑、按應用、按最終用途、按地區 - 產業預測，2024-2031年

Drug Delivery Devices Market Size, Share, Growth Analysis, By Route of Administration (Oral, Injectable), By Application (Oncology, Infectious Diseases), By End-use (Hospitals, Diagnostic Centers), By Region -Industry Forecast 2024-2031.

出版日期: 2024年11月20日 | 出版商:

SkyQuest | 英文 212 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球給藥市場規模為2,623億美元，預計從2023年的2,777.8億美元成長到2031年的4,394億美元，年複合成長率為5.90%。

由於擴大採用先進技術，有助於將治療劑精確輸送到目標部位並提高治療效果，藥物傳輸市場經歷顯著成長。這些設備不僅最佳化藥物傳輸、最大限度地減少劑量並減少潛在的副作用，而且還透過減少對原料藥的需求來節省成本。對新藥物輸送解決方案不斷成長的需求推動該領域的研究和開發舉措，目前的研究重點是提高設備的可及性、準確性和便利性。產業公司正積極追求創新技術進步，以開發下一代藥物輸送系統。此外，生物製藥行業的快速擴張刺激各種疾病新療法的開發，進一步增加了市場的成長潛力。製藥公司對臨床試驗的財務投資增加，加上 FDA 和 EMA 等監管機構的支持作用，促進醫療保健環境中創新藥物和給藥方法的出現。因此，藥物輸送設備市場預計將在如此活躍的環境中不斷進步並引進尖端解決方案。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東、非洲

競爭資訊

前5名企業比較
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 依細分市場分類的佔有率分析
- 收益與前一年同期比較（2021-2023）

主要企業簡介

Pfizer, Inc.
Novartis AG
BD
Bayer AG
UniQure NV
Sibiono GeneTech Co. Ltd.
West Pharmaceutical Services Inc.
Merck
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline PLC
Holozymes Inc.
Altaris
Elcam Medical
Fresenius Medical Care
Philips Healthcare
Novo Nordisk
Teva Pharmaceutical
Eli Lilly and Company
CSL Behring
Amgen Inc.

結論和建議

簡介目錄

Product Code: SQMIG35A2918

Global Drug Delivery Devices Market size was valued at USD 262.30 billion in 2022 and is poised to grow from USD 277.78 billion in 2023 to USD 439.40 billion by 2031, growing at a CAGR of 5.90% during the forecast period (2024-2031).

The market for drug delivery devices is experiencing significant growth, driven by the increasing adoption of advanced technologies that facilitate precise delivery of therapeutics to target sites, thus enhancing treatment efficacy. These devices not only optimize drug administration, thereby minimizing dosages and reducing potential side effects, but they also contribute to cost reductions by decreasing the need for active pharmaceutical ingredients. The surging demand for novel drug delivery solutions is propelling research and development initiatives within this space, with ongoing studies focused on enhancing device accessibility, accuracy, and patient-friendliness. Industry players are actively pursuing innovative technology advancements to create next-generation drug delivery systems. Additionally, the biopharmaceutical sector's rapid expansion is stimulating the development of new therapeutic agents for various diseases, further amplifying the market's growth potential. Increased financial investments by pharmaceutical companies in clinical trials, coupled with the supportive roles of regulatory bodies such as the FDA and EMA, are fostering the emergence of innovative drugs and delivery methodologies in the healthcare landscape. As a result, this thriving environment positions the drug delivery device market for continued advancement and the introduction of cutting-edge solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Delivery Devices Market Segmental Analysis

Global Drug Delivery Devices Market is segmented into Route of Administration, Application, End-use, and region. By Route of Administration, the market is classified into Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical, Others. Depending on the Application, it is categorized into Oncology, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others. According to End-use, the market is divided into Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Drug Delivery Devices Market

The Global Drug Delivery Devices market is significantly propelled by rising government investments in healthcare initiatives. Enhanced funding from federal sources is expected to accelerate market growth, particularly as the healthcare sector expands through both public and private investments, especially in developing countries. Furthermore, government efforts aimed at ensuring access to effective treatments for various conditions-such as cancer, infectious diseases, respiratory ailments, diabetes, and cardiovascular disorders-particularly in underserved areas, are poised to create substantial growth opportunities. This commitment to improving healthcare access is a critical driver of innovation and expansion in the drug delivery devices market.

Restraints in the Global Drug Delivery Devices Market

The Global Drug Delivery Devices market faces significant restraints due to intense competition from alternative drug delivery systems such as oral medications, intravenous injections, and transdermal patches. These alternatives present viable options that can sway the decision of healthcare providers and patients alike, influenced by various factors including the specific treatment requirements, individual patient preferences, and the inherent properties of the medications in question. This competition can create challenges for subcutaneous drug delivery devices as healthcare professionals and patients weigh the pros and cons of different administration methods, thereby potentially impacting the growth and adoption of such devices in the market.

Market Trends of the Global Drug Delivery Devices Market

The Global Drug Delivery Devices market is witnessing a notable trend characterized by an increasing emphasis on biosimilars and biologics, significantly driving the demand for subcutaneous drug delivery systems. This growth is largely attributed to the practical and efficient administration methods these devices provide, facilitating the targeted delivery of biologics and biosimilars for complex disorders. As healthcare systems transition towards personalized medicine, the convenience of subcutaneous administration is gaining prominence, ensuring patients can receive effective treatments with minimal discomfort. This shift not only enhances patient compliance but also propels innovation and investment in the drug delivery device sector, setting the stage for sustained market expansion.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Value Chain Analysis
Case Study Analysis
PESTEL Analysis
Market Attractiveness Index
Pricing Analysis

Global Drug Delivery Devices Market Size by Route of Administration & CAGR (2024-2031)

Market Overview
Oral
Inhalation
Transdermal
Injectable
Ocular
Nasal
Topical
Others

Global Drug Delivery Devices Market Size by Application & CAGR (2024-2031)

Market Overview
Oncology
Infectious Diseases
Respiratory Diseases
Diabetes
Cardiovascular Diseases
Autoimmune Diseases
Central Nervous System Disorders
Others

Global Drug Delivery Devices Market Size by End-use & CAGR (2024-2031)

Market Overview
Hospitals
Diagnostic Centers
Ambulatory Surgery Centers/Clinics
Home Care Settings
Others

Global Drug Delivery Devices Market Size & CAGR (2024-2031)

North America, (Route of Administration, Application, End-use)
- US
- Canada
Europe, (Route of Administration, Application, End-use)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Route of Administration, Application, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Route of Administration, Application, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa, (Route of Administration, Application, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Pfizer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
UniQure N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sibiono GeneTech Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Holozymes Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altaris
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elcam Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Medical Care
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CSL Behring
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments